Specialist For Animal Health

Adhering to "market-oriented, customer demand as our mission" R&D strategy, our company invests large funds for research and development. We built up a joint laboratory with Shanghai Tongji University, forcusing on veterinary industry tendency and developing non-patent synthetic route of the APIs under patent protection. For the past decade, we have successfully developed Tulathromycin, Gamithromycin, Cefovecin, etc.